Although tolvaptan bests fluid restriction at raising plasma sodium concentration, 19% of patients experience overcorrection ...

In sum, the nonapeptide Oxytocin presents as a structurally well-defined peptide with a receptor system that is widely ...

BioVie is eyeing a $19.7 million IPO for a spinout focused on bringing a new formulation of an approved kidney failure drug to market as a potential treatment for liver disease. | BioVie is eyeing a ...

Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.

This piece explaining the science behind love and loneliness is by Ng Cheng Jie, 17, one of three winners of a nationwide science journalism competition – the Singapore Biology Reporting Challenge.

There are no 'safe use guarantees', but it's possible to reduce harm.

Retex Pharmaceuticals Inc. has patented vasopressin V2 receptor antagonists potentially useful for the treatment of hyponatremia, cardiovascular disorders, autosomal dominant and autosomal recessive ...

As millions begin using weight-loss drugs, a new question is surfacing online and in medical discussions: could these medications also influence romantic desire or intimacy?

Another older, small study of 32 older adults found that MK-677 boosted levels of growth hormone in participants to a level that’s often found in younger adults. But this was a small study and only ...

The Therapeutic Goods Administration (TGA) is Australia's regulator of medicines, medical devices and biologicals. The TGA assesses therapeutic goods ...

Desmoda (desmopressin acetate) Vasopressin 2 receptor agonist Management of central diabetes insipidus as antidiuretic replacement therapy for adults and pediatric patients. FDA Approves Desmoda Oral ...